Has Tanzania embraced the green leaf? results from outlet and household surveys before and after implementation of the affordable medicines facility - Malaria

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Thomson, Rebecca ^a,b   Festo, Charles ^b   Johanes, Boniface ^b   Kalolella, Admirabilis ^b   Bruxvoort, Katia ^a,b   Nchimbi, Happy ^b   Tougher, Sarah ^a   Cairns, Matthew ^a   Taylor, Mark ^a,c   Kleinschmidt, Immo ^a   Ye, Yazoume ^d   Mann, Andrea ^a   Ren, Ruilin ^d   Willey, Barbara ^a   Arnold, Fred ^d   Hanson, Kara ^a   Kachur, S Patrick ^e   Goodman, Catherine ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c TRNAVA UNIVERSITY   (Slovakia)

^d ICF INTERNATIONAL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISININ; CHLOROQUINE; MEFLOQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG MARKETING; DRUG STORAGE; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEALTH CARE NEED; HEALTH PROGRAM; HEALTH SURVEY; HELP SEEKING BEHAVIOR; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PHARMACY; PUBLIC HEALTH SERVICE; QUALITY CONTROL; TANZANIA; ECONOMICS; FAMILY SIZE; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROGRAM EVALUATION; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TRENDS;

ANTIMALARIALS; ARTEMISININS; DRUG COSTS; FAMILY CHARACTERISTICS; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HUMANS; MALARIA; PHARMACIES; PRIVATE SECTOR; PROGRAM EVALUATION; PUBLIC SECTOR; SURVEYS AND QUESTIONNAIRES; TANZANIA;

EID: 84901276341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095607     Document Type: Article

References (32)

1. McNeil DG (2009) Plan Tries to Lower Malaria Drug Cost, in New York Times
2. The Global Fund to Fight AIDS Tuberculosis and Malaria (2008) Affordable Medicines Facility-malaria. Geneva.
3. World Health Organization (2012) World Malaria Report
4. Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, et al. (2009) Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One 4(9): e6857.
5. Talisuna AO, Adibaku S, Amojah CN, Amofah GK, Aubyn V, et al (2012) The Affordable Medicines Facility-malaria - a success in peril. Malar J 11: 370.
6. Patouillard E, Hanson KG, Goodman CA (2010), Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malar J 9: 50.
7. Dondorp AM, Fairhurst RM, Slutsker L, Macartheur JR, Breman JG, et al. (2011) The threat of artemisinin-resistant malaria. N Engl J Med 365(12): 1073-5.
8. Arrow KJ, Panosian C, Gelband H (2004) Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. The National Academies Press.
9. Tougher S, ACTWatch Group, Ye Y, Amuasi JH, Kougueni IA, et al. (2012) Effect of the Affordable Medicines Facility - malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 380(9857): 1916-26.
10. Adeyi O, R Atun (2010) Universal access to malaria medicines: innovation in financing and delivery. Lancet 376(9755): 1869-71.
11. Kamal-Yanni M (2010) Affordable medicines facility for malaria: reasonable or rash? The Lancet 375(9709): 121.
12. Moon S, Perez Casas C, Kindermans JM, de Smet M, von Schoen-Angerer T (2009) Focusing on quality patient care in the new global subsidy for malaria medicines. PLoS Med 6(7): e1000106.
13. Tanzania National Malaria Control Programme (2008) Coverage of mosquito nets, IPTp, the prevalence of parasitemia and anaemia in selected districts.
14. Tanzania National Malaria Control Programme (2010) Tanzania Malaria Programme Review.
15. Njau JD, Goodman C, Kachur SP, Palmer N, Khatib RA, et al. (2006) Fever treatment and household wealth: the challenge posed for rolling out combination therapy for malaria. Trop Med Int Health 11(3): 299-313. (Pubitemid 43357053)
16. Sillo H, Kimatta S (2012) Engaging Private Sector Retail Drug Outlets to Improve Access to Essential Medicines in Rural Tanzania: Experience from the Accredited Drug Dispensing Outlet (ADDO) Program: Tanzania Food and Drug Authority (TFDA).
17. United Republic of Tanzania Ministry of Health and Social Welfare (2011) National Guidelines for Diagnosis and Treatment of Malaria, in Malaria control series 25. National Malaria Control Program. Dar es Salaam, Tanzania.
18. Bruxvoort K, Kalolella A, Nchimbi H, Festo C, Taylor M, et al. (2013) Getting ACTs on target: Impact of national rollout of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania. Trop Med Int Health 18(10): 1269-82
19. AMFm Independent Evaluation Team (2012) Independent evaluation of phase 1 of the Affordable Medicines Facility- malaria (AMFm), multi-country independent evaluation report: final report. ICF International and the London School of Hygiene and Tropical Medicine: Calverton, Maryland and London
20. Shewchuk T, O'Connell K, Goodman C, Hanson K, Chapman S, et al. (2011) The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malaria Journal (10): 325.
21. The Global Fund to Fight AIDS Tuberculosis and Malaria (2010) Global Fund Quality Assurance policy for pharmaceutical products. Geneva.
22. O'Connell KA, Gatakaa KA, Poyer S, Njogu J, Evance I, et al. (2011) Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J 10: 326.
23. Tanzania Commission for AIDS (TACAIDS)/Zanzibar AIDS Commission (ZAC)/National Bureau of Statistics (NBS)/Office of the Chief Government Statistician (OGS) and Macro International Inc. (2012) Tanzania HIV/AIDS and Malaria Indicator Survey 2011-12. TACAIDS,ZAC, NBS, OCGS, and Macro International Inc. Dar es Salaam, Tanzania
24. National Bureau of Statistics (Tanzania) and ICF Macro (2011) Tanzania Demographic and Health Survey 2010 NBS and ICF Macro: Dar es Salaam, Tanzania.
25. Allen DR, Metta E, Mkoba C, Goodman C, Abdulla S, et al. (2011) 'They just told me to go and buy drugs from the shop.' How the 2010 ACT stock outs in Tanzania affected malaria care-seeking behaviour in Mtwara region. Poster ASTMH
26. Yadav P, Cohen JL, Alphs S, Arkedis J, Larson PS, et al. (2012) Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania. Malar J 11: 299.
27. Cohen J, Prashant Y, Moucheraud C, Alphs S, Larson P, et al. (2013) Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania. Plos One 8(7): e70713.
28. AMFm Independent Evaluation Team (2012) Independent Evaluation of phase 1 of the Affordable Medicines Facility - malaria (AMFm), multi-country independent evaluation report: supplementary report on ACT use based on household surveys. ICF International and London School of Hygiene and Tropical Medicine: Calverton, Maryland and London.
29. Global Fund news release. November 15, 2012. Board Approves Integration of AMFm into Core Global Fund Grant Processes
30. Briggs MA, Kalolella A, Bruxvorrt K, Weigand R, Lopez G, et al. (2014) Prevalence of malaria parasitemia and purchase of artemisinin-based Combination therpaies among drug shop clients in two regionsIn Tanzania with ACT subsidies in Tanzania. Plos One 9(4): e94074
31. The Global Fund to Fight AIDS Tuberculosis and Malaria (2013) Diagnostic Testing in the Retail Private Sector: Lessons Learned London.
32. Yeung S, Patouillard E, Allen H, Socheat D (2011) Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia. Malar J 10: 243.